In the news

Interview with Pierre Jérôme and Stéphane Bette: Full-Year 2023 Results and First Quarter 2024 Sales, New Products Launching Plan and Company’s outlook

23-April-2024 – 18h00 CE(S)T

SpineGuard announces its full-year 2023 financial results and its first quarter 2024 sales

17-April-2024 – 18h00 CE(S)T

Interview with Pierre Jérôme: More insights on the achievement of key milestones and SpineGuard’s outlook for 2024

19-Februray-2024 – 18h00 CE(S)T

SpineGuard reaches the milestone of 100,000 surgeries and over 30 publications with DSG® technology

06-February-2024 – 18h00 CE(S)T

SpineGuard announces its 2024 financial calendar

20-December-2023 – 18h00 CE(S)T

Completion of the capital increase with shareholders’ preferential subscription rights for a gross amount of €1.5 million

07-December-2023 – 08h30 CE(S)T

TechMed Infos: Three Questions to Pierre Jérôme and Stéphane Bette

29-September-2023 – 10h00 CE(S)T

SpineGuard reports six-month 2023 financial results

12-September-2023 – 18h15 CE(S)T

SpineGuard strengthens its intellectual property with a new patent granted in Brazil

05-September-2023 –18Xh30 CE(S)T

SpineGuard secures a € 7.5M equity line with Nice & Green. Cash runway extended to the end of 2026.

31-May-2023 – 18h00 CE(S)T

Patricia Lempereur comes back on 2022 sales performances and shares 2023 business outlook.

28-March-2023 – 18h00 CE(S)T

Robotic detection of bone breach via SpineGuard’s DSG® technology: 100% efficacy proven again in lab experiment

08-March-2023 – 18h00 CE(S)T

The French Academy of Medicine grants the prestigious Charpak-Dubousset prize to research work for the prevention of bone breach in robotic surgery by the DSG® technology of SpineGuard

13-December-2022 – 18h00 CE(S)T

SpineGuard Reports on its Extraordinary Shareholders Meeting held on 23 September 2021

23-September-2021 – 16h00 CE(S)T

Annual Shareholders’ Meeting SpineGuard 9 June 2021

21-May-2021 – 08h00 CE(S)T

Video SpineGuard and Carnot Interfaces (in french): quand la stratégie d’une PME des MedTech rencontre celle d’un laboratoire

September-2019

Interview of Stéphane Bette, CEO of SpineGuard and Guillaume Morel, Director of Institut Tremplin Carnot - Professor of Sorbonne University - Director of ISIR (Sorbonne Université/CNRS/INSERM) regarding their partnership on robotics.

SpineGuard’s scientific article “Robot-assisted spine surgery guided by conductivity sensing: first preclinical experiments demonstrate X-ray free breach detection”

8-July-2019

Letter of innovation from CNRS on surgical robotic guidance in real time thanks to the DSG Technology

20-June-2019

Interview of Stéphane Bette, SpineGuard’s CEO and Co-Founder, for DM magazine

October-2018

SpineGuard: Riding robotic’s wave, from David Cassak, MedTech Strategist

28-September-2018

Professor Yong QIU, Chairman of Orthopedic Surgery of Nanjing Drum Tower Hospital, performed the first surgery in China with the PediGuard® in spinal deformity.

18-April-2018

How value-based spine care shapes technology development

31-March-2016

Key thoughts on SpineGuard – featured article in Becker’s Healthcare

Pierre Jerome, SpineGuard’s CEO and co-founder, was invited to speak at the Canaccord Genuity Musculoskeletal Conference in Orlando, Florida, on March 1, 2016

01-March-2016

He shared SpineGuard’s vision during his presentation, where he says, “there is a real need for innovation and differentiation in the spine space where pedicle screws are used”. This presentation and the Q&A that followed was webcast live. A recording of the webcast can be accessed by

SpineGuard – Taming the Screw: Much of the innovation in spine over the past decade has aimed at replacing fusion, still the standard of care

21-July-2013

SpineGuard’s novel sensor technology is betting on fusion’s long-term prospects, helping patients and surgeons by making the procedure safer.
Pdf Version

Spineguard raised €8.1 million in Successful IPO (on NYSE Alternext), for growth, expansion and development.

29-April-2013

SpineGuard (EPA:ALSGD) said its initial public offering on Europe’s Alternext exchange raised some €8.1 million, or roughly $10.5 million

29-April-2013

The Paris-based medical device company makes the PediGuard device, designed to help guide the placement of pedicle screws during spinal fusion surgeries.

SpineGuard raises $11 million and acquired PediGuard business unit from SpineVision, Inc.

09-April-2009